STERIS (STE) Q1 2026 Earnings
STERIS reported Q1 2026 revenue of $1.6B (+7.3% YoY), missed analyst consensus of $1.6B by $6.2M. Diluted EPS came in at $2.83 (+3.3% YoY), missed the $2.86 consensus by $0.03. STERIS reports across 3 business segments, led by Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.
Financial Snapshot
Trailing eight quarters through Q1 2026 — latest period from 8-K press release; updates when 10-Q/10-K is filed
Q1 2026 Earnings FAQ
Common questions about STERIS's Q1 2026 earnings report.
STERIS (STE) reported Q1 2026 earnings on May 11, 2026 after market close.
STERIS reported revenue of $1.6B and diluted EPS of $2.83 for Q1 2026.
Revenue missed the consensus estimate of $1.6B by $6.2M. EPS missed the consensus estimate of $2.86 by $0.03.
Compared to the same quarter a year prior, revenue grew 7.3% from $1.5B a year earlier and diluted EPS grew 3.3% from $2.74.
You can read the 8-K earnings release (0001628280-26-033580) directly on SEC EDGAR. The filing index links above go to sec.gov.